Moses Makunje
Financieel Directeur/CFO bij NUVATION BIO INC.
Vermogen: 27 803 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| David Hung | M | 66 | 6 jaar | |
| Kim Blickenstaff | M | 71 | 5 jaar | |
| Kathryn Falberg | F | 63 | 4 jaar | |
| Robert D. Mashal | M | - | - | |
| Tony Vernon | M | 68 | 5 jaar | |
| Robert Bazemore | M | 56 | 4 jaar | |
| Jonathan Lim | M | 52 |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 5 jaar |
| Kerry Wentworth | F | 51 | 2 jaar | |
| Daniel Welch | M | 66 | 4 jaar | |
| Richard Scheller | M | 70 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 5 jaar |
| Gary Hattersley | M | 57 | 5 jaar | |
| Stacy Markel | F | 59 | 5 jaar | |
| David Hanley | M | 54 | 3 jaar | |
| Dong Fang Liu | M | 54 | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Oleg Nodelman | M | 47 | 2 jaar | |
| Jennifer Fox | F | 53 | 3 jaar | |
| Lisa V. DeLuca | M | - | - | |
| Thomas S. Templeman | M | 64 | 2 jaar | |
| Sergey Yurasov | M | 55 | 3 jaar | |
| Michelle Doig | F | 50 | 2 jaar | |
| Alex Colville | M | - |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 21 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Moses Makunje
- Persoonlijk netwerk
